Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...

A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.

Clinically important arrhythmias, especially nonsustained ventricular tachycardia (NSVT), may be more prevalent in patients with hypertrophic cardiomyopathy (HCM) than widely believed, suggests a ...

A Hypertrophic Cardiomyopathy Center or a Lone Cardiologist?

Patients with hypertrophic cardiomyopathy (HCM) must be assessed using a 24- or 48-hour Holter monitor at least every 2 years to identify atrial fibrillation (AFib) or nonsustained ventricular ...

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...

Please provide your email address to receive an email when new articles are posted on . AI module for the detection of hypertrophic cardiomyopathy gains de vovo FDA approval. The module is integrated ...

Learn how hypertrophic cardiomyopathy (HCM) affects families, the importance of genetic testing, and why regular screening is ...

Real-world evidence to be presented at the American College of Cardiology Scientific Session 2025 demonstrates positive impact of Viz.ai on disease detection and care coordination SAN ...

The use of 24-48 hour Holter monitoring is recommended to detect atrial fibrillation and NSVT in patients with HCM. 5 Extended ECG monitoring has previously been shown to improve detection of atrial ...